SelectQuote, Inc. Investor News: If You Have Suffered Losses in SelectQuote, Inc. (NYSE: SLQT), You Are Encouraged to Contact Th

Posted Jun 30 by Two Blokes

NEW YORK, June 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues

Source: Two Blokes Trading

An investor in the narcolepsy drugmaker Avadel Pharmaceuticals plans to call for shareholders to vote out the company's entire b

Posted Jun 30 by Two Blokes

ASL Strategic Value Fund wants the narcolepsy drugmaker to retain investment bankers and consider a sale.

Source: Two Blokes Trading

Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generat

Posted Jun 30 by Two Blokes

SAN FRANCISCO and SUZHOU, China , June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 0

Source: Two Blokes Trading

Is Citigroup A 'Buy' Following The Fed's Stress Tests?

Posted Jun 30 by Two Blokes

Citigroup remains the cheapest large U.S. bank by price-to-book, justified by its higher risk profile and belo

Source: Two Blokes Trading

Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Pro

Posted Jun 30 by Two Blokes

Press Release Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine

Source: Two Blokes Trading

Changes to the Roche Enlarged Corporate Executive Committee

Posted Jun 30 by Two Blokes

Basel, 30 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Johannes (Hans) Clevers (1957),

Source: Two Blokes Trading

A factory in a lab: Idorsia's breakthrough synthetic glycan vaccine platform validated for the first time in humans

Posted Jun 30 by Two Blokes

Ad hoc announcement pursuant to Art. 53 LR Potential first-ever vaccine directed against C.

Source: Two Blokes Trading

Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders

Posted Jun 30 by Two Blokes

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland – June 30, 2025 – Addex Therapeutics (SIX: ADXN

Source: Two Blokes Trading

Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy

Posted Jun 30 by Two Blokes

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Two

Source: Two Blokes Trading

SEALSQ Finalizes Strategic Investment in WeCan Group with 28.30% Equity Stake Acquisition

Posted Jun 30 by Two Blokes

Geneva, Switzerland, June 30, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a c

Source: Two Blokes Trading

LPRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Open Lending Corporation Investors with Substantial Losses

Posted Jun 30 by Two Blokes

NEW YORK, June 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nati

Source: Two Blokes Trading

RKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Companies, Inc. Investors with Substantial Losses Ha

Posted Jun 30 by Two Blokes

NEW YORK, June 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nati

Source: Two Blokes Trading